We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Nova Science Publishers Inc Sickle Cell Disease: A New Vision for an Old Problem (Recent Advances in Hematology Research)
Price data last checked 102 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Sickle cell hemoglobin (HbS) is the result of a single nucleotide change (GAG → GTG) in the β-globin gene, where valine replaces glutamic acid at the sixth amino acid position in the β-globin chain. Sickle cell disease is a growing global health problem. The World Health Organization has estimated that 7% of the world population has the mutation and 300,000400,000 affected children are born every year. The disease progresses towards a severe chronic hemolytic anemia, and it shows a heterogeneous clinical course, related with different genetic factors. Despite the fact that all subjects with sickle cell disease (SCD) have the same single base pair mutation in the DNA, we further confirmed here that the severity of the clinical and hematological manifestations is extremely variable. Increasing evidence has indicated a role of oxidative stress in the vascular pathophysiology of SCD. The vascular endothelium is central to disease pathogenesis because it displays adhesion molecules for blood cells, balances procoagulant and anticoagulant properties of the vessel wall and regulates vascular homeostasis by synthesizing vasoconstricting and vasodilating substances. In addition, recent studies support the existence of a hyperoxidative status in SCD patients that may account, at least in part, for the clinical manifestations of these patients. Moreover, SCD patients with mild clinical outcomes were associated with low oxidative status, whereas high oxidative stress was related to severe phenotypes. Thus, the use of oxidative stress biomarkers may be important in the evaluation of the clinical condition of SCD patients, whereas the use of therapies to improve their redox status and increase NO bioavailability would be beneficial to reduce the severity of sickle disease. The global burden of SCD is now significantly increased and, thus, it is currently a public health problem around the world. This disease has passed from being a problem of the developing countries to affect many people in developed countries. This book summarizes the current epidemiology status and the latest discoveries in the pathophysiology of SCD, and the potential therapies that may improve the clinical course of this disease.
Product Specifications
- Format
- Hardcover
- ASIN
- 1622574699
- Domain
- Amazon UK
- Release Date
- 01 July 2013
- Listed Since
- 12 April 2013
Barcode
No barcode data available
Similar Products You Might Like
95% match
New Developments in Sickle Cell Disease Research
£116.47
12 Mar 2026
94% match
The Pathophysiology of Sickle Cell Disease: Cellular, Molecular and Biochemical Mechanisms
VDM Verlag
£57.81
08 Mar 2026
94% match
Focus on Sickle Cell Research
£25.25
09 Mar 2026
94% match
Sickle Cell Disease: Pathophysiology, Diagnosis, and Management
Praeger
£61.07
07 Mar 2026
94% match
RENAISSANCE OF SICKLE CELL DISEASE RESEARCH IN THE GENOME ERA
Imperial College Press
£67.09
11 Mar 2026
94% match
Springer - Sickle Cell Anemia: Basic Science to Clinical Practice
Springer
£109.79
22 Feb 2026
94% match
Fetal Hemoglobin: The Panacea for Major Beta-Hemoglobinopathies
£155.99
20 Apr 2026
93% match
Gene and Cell Therapies for Beta-Globinopathies: 1013 (Advances in Experimental Medicine and Biology, 1013)
Springer
£107.85
09 Mar 2026
93% match
Sickle Cell Disease
McGraw-Hill Education
£113.35
14 Jan 2026
93% match
Hemoglobin and Its Diseases (Cold Spring Harbor Perspectives in Medicine)
Cold Spring Harbor Laboratory Press
£79.00
06 Mar 2026
93% match
THALASSEMIA CAUSES TREATMENT OPTIONS: Causes, Treatment Options & Long-Term Health Outcomes (Recent Advances in Hemotology Research)
Nova Science Publishers Inc
£127.31
14 Jan 2026
92% match
Genetics and Global Public Health: Sickle Cell and Thalassaemia
Routledge
£55.62
09 Jan 2026
92% match
Anemia: Prevalence, Risk Factors & Management Strategies (Recent Advances in Hematology Research)
£30.63
08 Mar 2026
92% match
Hematology: Basic Principles and Practice
Elsevier
£238.03
12 Jan 2026
92% match
Oxidative Stress and Antioxidant Defense: Biomedical Value in Health and Diseases
£140.18
11 Jan 2026
92% match
The Many Faces and Lives of Sickle Cell - A Global Collaboration
£38.34
07 Mar 2026
92% match
Haemoglobinopathy Diagnosis
£103.48
14 Jan 2026
92% match
Progress in Iron Research: Proceedings of the Fourth International Conference on Hemochromatosis and Clinical Problems in Iron Metabolism and the ... in Experimental Medicine and Biology)
Springer
£103.03
09 Mar 2026
92% match
Advances in Hypertension Research - Medical Research Book
£134.72
20 Apr 2026
92% match
Medical and Surgical Complications of Sickle Cell Anemia
Springer
£85.07
04 Apr 2026
92% match
Medical and Surgical Complications of Sickle Cell Anemia
Springer
£74.74
29 Jan 2026
92% match
Disseminated Intravascular Coagulation (DIC): Clinical Manifestations, Diagnosis & Treatment Options (Recent Advances in Hematology Research)
£67.68
24 Feb 2026
92% match
Pediatric Hematology: Methods and Protocols: 91 (Methods in Molecular Medicine, 91)
Humana
£72.56
08 Mar 2026
92% match
Studies on Cardiovascular Disorders (Oxidative Stress in Applied Basic Research and Clinical Practice)
Humana
£156.07
08 Jan 2026